Evidence map›Paper›PMID 25183261›Full record

ArticleNature communications2014

Microfluidic platform for the quantitative analysis of leukocyte migration signatures.

Leo Boneschansker, Jun Yan, Elisabeth Wong, David M Briscoe, Daniel Irimia

Abstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Chemical and Mechanical Regulation of Leukocyte Migration.Cold Spring Harbor perspectives in biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Immunomodulation by allograft endothelial cells.Frontiers in transplantation · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Tissue Models forFrontiers in cellular and infection microbiology · 2022
    Review
  16. Article
  17. Point-of-critical-care diagnostics for sepsis enabled by multiplexed micro and nanosensing technologies.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leo Boneschansker *Transplant Research Program and The Division of Nephrology, Department of Medicine, Boston Children's Hospital, Boston, MA 02115, and the Department of Pediatrics, Harvard Medical School, Boston, MA 02115.
Jun Yan *BioMEMS Resource Center, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA 02129.
Elisabeth WongBioMEMS Resource Center, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA 02129.
David M BriscoeTransplant Research Program and The Division of Nephrology, Department of Medicine, Boston Children's Hospital, Boston, MA 02115, and the Department of Pediatrics, Harvard Medical School, Boston, MA 02115.
Daniel IrimiaBioMEMS Resource Center, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Shriners Hospitals for Children, Boston, MA 02129.

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
Bio-MicroElectroMechanical Systems Resource CenterP41EB002503 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET · 2004 to 2018
$17.4M
TRAINING IN TRANSPLANTATION BIOLOGYT32AI007529 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1998 to 2024
$6.4M
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGYT32DK007726 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 1994 to 2023
$5.9M
Neutrophil Decision Making in Confined Environments in Health and DiseaseR01GM092804 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI IRIMIA, DANIEL · 2010 to 2022
$4.3M
ANGIOGENESIS AND CHRONIC REJECTIONR01AI046756 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 2000 to 2010
$4.2M
Vascular Endothelial Growth Factor Receptor Interactions and Allograft RejectionR01AI092305 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI BRISCOE, DAVID M. · 2012 to 2016
$2.8M
NIAID NIH HHS AI04675NIAID NIH HHS AI092305NIAID NIH HHS R01 AI046756NIAID NIH HHS R01 AI092305NIAID NIH HHS T32 AI007529NIAID NIH HHS T32AI007529NIBIB NIH HHS EB002503NIBIB NIH HHS P41 EB002503NICHD NIH HHS P30 HD018655NICHD NIH HHS P30-HD18655NIDDK NIH HHS T32 DK007726NIDDK NIH HHS T32DK07726NIGMS NIH HHS GM092804NIGMS NIH HHS R01 GM092804
6 · The paper itself

Abstract

Leukocyte migration into tissues is characteristic of inflammation. It is usually measured in vitro as the average displacement of populations of cells towards a chemokine gradient, not acknowledging other patterns of cell migration. Here, we designed and validated a microfluidic migration platform to simultaneously analyse four qualitative migration patterns: chemoattraction, -repulsion, -kinesis and -inhibition, using single-cell quantitative metrics of direction, speed, persistence and fraction of cells responding. We find that established chemokines, complement component 5a and IL-8 induce chemoattraction and repulsion in equal proportions, resulting in the dispersal of cells. These migration signatures are characterized by high persistence and speed and are independent of the chemokine dose or receptor expression. Furthermore, we find that twice as many T lymphocytes migrate away than towards stromal cell-derived factor 1 and their directional migration patterns are not persistent. Overall, our platform helps discover migratory signature responses and uncovers an avenue for precise characterization of leukocyte migration and therapeutic modulators.

Indexed as

Chemokine CXCL12ChemotaxisComplement C5aHumansInterleukin-8Leukotriene B4Lymphocyte CountMicrofluidic Analytical TechniquesN-Formylmethionine Leucyl-PhenylalaninePrimary Cell CultureT-LymphocytesChemokine CXCL12Complement C5aCXCL12 protein, humanInterleukin-8Leukotriene B4N-Formylmethionine Leucyl-Phenylalanine

Identifiers

PMID25183261
PMCPMC4155519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.